Up a level |
Nicoletti, Paola, Devarbhavi, Harshad, Goel, Ashish, Venkatesan, Radha, Eapen, Chundamannil E, Grove, Jane I, Zafer, Samreen, Bjornsson, Einar, Lucena, M Isabel, Andrade, Raul J et al (show 8 more authors)
(2020)
Genetic risk factors in drug-induced liver injury due to isoniazid-containing anti-tuberculosis drug regimens.
Clinical Pharmacology and Therapeutics, 109 (4).
pp. 1125-1135.
Cirulli, Elizabeth T, Nicoletti, Paola, Abramson, Karen, Andrade, Raul J, Bjornsson, Einar S, Chalasani, Naga, Fontana, Robert J, Hallberg, Par, Li, Yi Ju, Lucena, M Isabel et al (show 29 more authors)
(2019)
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
Gastroenterology, 156 (6).
pp. 1707-1716.
Larrey, Dominique, Puoti, Massimo, Piekarska, Anna, Back, David, Marra, Fiona ORCID: 0000-0003-1326-1149, Bondin, Mark, Raheja, Ritu, Zhang, Zhenzhen, Kalluri, Hari V, Marcinak, John et al (show 1 more authors)
(2020)
POLYPHARMACY IN HCV-INFECTED PATIENTS WHO USE DRUGS TREATED WITH GLECAPREVIR/PIBRENTASVIR: A REAL-WORLD ANALYSIS FROM 9 COUNTRIES.
.
Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors)
(2019)
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
JOURNAL OF VIRAL HEPATITIS, 26 (6).
pp. 685-696.